CG Oncology Inc. (NASDAQ: CGON) Stock Information | RedChip

CG Oncology Inc. (NASDAQ: CGON)


$28.6650
-0.0050 ( +0.05% ) 0.0K

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Market Data


Open


$28.6650

Previous close


$28.6700

Volume


0.0K

Market cap


$2.18B

Day range


$28.5510 - $28.6500

52 week range


$25.7700 - $50.2300

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 17, 2024
4 Insider transactions 1 Dec 17, 2024
4 Insider transactions 1 Dec 06, 2024
8-k 8K-related 15 Dec 05, 2024
8-k 8K-related 13 Nov 12, 2024
10-q Quarterly Reports 64 Nov 12, 2024
4 Insider transactions 1 Oct 08, 2024
4 Insider transactions 1 Oct 07, 2024
4 Insider transactions 1 Oct 07, 2024
4 Insider transactions 1 Oct 07, 2024

Latest News